U.S. Waives Jones Act After Iran Gas Field Attack

"Worst-Case Scenario": Novo Nordisk Plunges After Next-Gen Obesity Drug Falls Short Of Lilly Rival Shares of Novo Nordisk A/S plummeted again on Monday after the company reported trial results showing its next-generation obesity shot, CagriSema, delivered 20.2% weight loss at 84 weeks, compared to 23.6% for Eli Lilly & Co.’s tirzepatide (Zepbound). Bloomberg Intelligence analyst Michael Shah explained, "This outcome is the worst-case scenario for Novo and heightens the need for M&A with Novo’s other GLP-1/Amylin drug." Shares of Novo in Copenhagen plunged as much as 16.5%, breaking below a support level...

"Historic Injustice": DOJ Settles With Retired Gen. Flynn For Malicious Russiagate Prosecution Authored by Troy Myers via The Epoch Times, The Department of Justice (DOJ) and retired Lt. Gen. Michael Flynn, a former national security adviser in President Donald Trump’s first term, reached an undisclosed financial settlement Wednesday, according to court documents. Flynn sought a $50 million payout from the government for what he claimed were politically motivated actions against him. The settlement brings an end to a years-long dispute that stemmed from false claims of Russian meddling in the 2016 presidential election. Once...

Panics, Politics, & Power: America's 3 Experiments With Central Banks Authored by Andrew Moran via The Epoch Times, The Federal Reserve, established more than a century ago, is the United States’ third experiment with central banking. For much of its existence, the institution maintained a low public profile. Only after the 2008 global financial crisis did the Fed begin communicating more openly, introducing post-meeting press conferences and allowing monetary policymakers to engage more frequently with the media. Greater transparency, however, has brought greater scrutiny. Public sentiment toward the Fed and its leadership has fluctuated over...